Climb Bio share price logo

Climb Bio

NASDAQ: CLYM

Small Cap

$10.19

-0.35

(-3.32%)

Live

as on

Climb Bio Stock Performance

as on October 24, 2026 at 6:24 am IST

  • Day's Low

    Day's High

    $10.05
    $10.46
    downward going graph

    1.37%

    Downside

    2.65%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.64
    $18.33
    downward going graph

    83.95%

    Downside

    79.88%

    Upside

    downward going graph

Climb Bio share price movements today

Previous Close
$10.54
Open
$10.46
Volume
319.6K
Market Cap
$624.3M
Day's Low - High
$10.05 - $10.46
52 Week Low - High
$1.64 - $18.33

Climb Bio Historical Returns

1 Month Return
-15.81 %
3 Month Return
-17.4 %
1 Year Return
+ 429.65 %
3 Year Return
0 %
5 Year Return
0 %

Climb Bio Stock Fundamentals & Key Indicators

Check Climb Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$624.3M

EPS (TTM)

-0.83

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-13.1

Industry PE ratio

-7.12

PEG Ratio

0.65

EBITDA

-59.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-31.79%

Climb Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Climb Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$624.3MNA-13.100.00%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Climb Bio Stock including INR - Dollar returns

The Climb Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Climb Bio investment value today

Current value as on today

₹5,53,834

Returns

₹4,53,834

(+453.83%)

Returns from Climb Bio Stock

₹4,12,060 (+412.06%)

Dollar Impact

₹41,774 (+41.77%)

Analyst Recommendation on Climb Bio Stock

Based on 9 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Climb Bio. Average target price of $29.125

Climb Bio Share Price Target

Get share price movements and forecasts by analysts on Climb Bio.

Current Price

$10.19

Analyzed by

9 Analysts

High

$40

0

Low

$18

Climb Bio target price $0, a slight upside of 0% compared to current price of $10.19. According to 9 analysts rating.

Indian Investors' Interest in Climb Bio Stock

Search interest for Climb Bio Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-28% versus previous 30 day period

Climb Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
0
-
0
0
-
Operating Income
-3
-56
-11
-10
-23
-10
-14
-19
-15
-15
EBITDA
-1
-54
-8
-8
-20
-8
-12
-17
-13
-15
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
0
0
0
0
0
Income Before Tax
-1
-54
-8
-8
-20
-8
-12
-17
-13
-13
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-54
-8
-8
-20
-8
-12
-17
-13
-13
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Climb Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
0
Operating Income
-7
-20
-35
-45
-40
-82
-67
EBITDA
-4
-11
-47
-45
-35
-30
-59
Interest Expense
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
0
Income Before Tax
-6
-20
-47
-45
-35
-73
-59
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-6
-20
-47
-45
-35
-73
-59
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Climb Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
-54
-8
-8
-20
-8
-12
-17
-13
-13
Operating Cash Flow
-1
0
-7
-5
-15
-11
-12
-15
-14
-10
Investing Cash Flow
13
-9
-71
-53
-42
4
15
25
-12
-57
Financing Cash Flow
0
128
2
0
-
-
-
0
0
103
Change in Cash
11
118
-76
-58
-58
-6
3
9
-27
35

Climb Bio Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-20
-47
-45
-35
-73
-59
Operating Cash Flow
-5
-14
-36
-37
-20
-15
-54
Investing Cash Flow
-
8
-114
34
68
-121
2
Financing Cash Flow
26
4
177
-
0
130
0
Change in Cash
21
0
26
-3
49
-5
-51

Global Institutional Holdings in Climb Bio

Check out the Institutions with significant holdings in Climb Bio.

Funds
Holdings
Peter Kolchinsky
19.68%
Vanguard
4.90%
Michael Rockefeller
2.75%
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
2.56%
iShares
2.45%

Climb Bio News & Key Events

  • img

    Today's Timeline - 03 September

    Thu, 05:47 PM

    -

    Climb Bio reports positive initial Phase 1 data for CLYM116, showing significant IgA reductions and favorable safety profile.

Insights on Climb Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CLYM stock has moved up by 429.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CLYM has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 242.3%

About Climb Bio

Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
OrganisationClimb Bio
Headquarters20 William Street, Wellesley Hills, MA, 02481, US
IndustryBiotechnology
CEOAoife Brennan BCh MMSc

Key Management of Climb Bio

Name

Title

Dr. Perrin Wilson B.S., Ph.D.

Chief Business Officer

Mr. Adam Villa

Senior Vice President of Technical Operations

Ms. Chandra Adams J.D.

Senior VP, General Counsel & Secretary

Ms. Ashley Jones

Senior Vice President of People & Workforce Strategy

Dr. Edgar D. Charles M.D., M.Sc.

Chief Medical Officer

Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc

CEO, President & Director

Dr. Susan Altschuller M.B.A., Ph.D.

CFO & Principal Accounting Officer

FAQs

What is Climb Bio share price today?

Climb Bio share price today is $10.19 as on . Climb Bio share today touched a day high of $10.46 and a low of $10.05.

What is the 52 week high and 52 week low for Climb Bio share?

Climb Bio share touched a 52 week high of $18.33 on and a 52 week low of $1.64 on . Climb Bio stock price today i.e. is trending at $10.19,which is 44.41% down from its 52 week high and 523.24% up from its 52 week low.

What is Climb Bio's market capitalisation today?

Climb Bio market capitalisation is $0.00T as on .

How to invest in Climb Bio Stock (CLYM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Climb Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Climb Bio Stock (CLYM) from India?

Indian investors can start investing in Climb Bio (CLYM) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Climb Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Climb Bio share’s latest price of $10.19 as on October 24, 2026 at 12:54 am IST, you will get 0.9814 shares of Climb Bio. Learn more about fractional shares .